Qi
Zhang

Dr. Qi Zhang received her PhD from the University of Marburg, Germany, and subsequently joined Emory University School of Medicine, Department of Pharmacology and Chemical Biology, as a postdoctoral fellow under the mentorship of Dr. Lian Li. She later advanced to Instructor and was promoted to Assistant Professor in 2024. She has over fifteen years of experience in mass spectrometry–based proteomics and glycoproteomics, with strong training in molecular and cell biology, as well as expertise in computational analysis, and international research experience at the Beijing Proteome Research Center, Nanyang Technological University, and the Max Planck Institute. Dr. Zhang’s research focuses on developing computational and systems biology approaches to model glycosylation as a structured, network-dependent molecular system, enabling systematic analysis of molecular remodeling in neurodegenerative diseases. She has established an integrated multi-omics pipeline that combines glycoproteomics, proteomics, transcriptomics, and clinical data, incorporating site-specific quantification, network analysis, and molecular–clinical modeling. Her current work integrates quantitative glycoproteomics, multi-omics data, and computational systems biology to investigate neurodegenerative diseases, particularly Alzheimer’s disease and related dementias, with a focus on studying molecular mechanisms and identifying glycosylation-based biomarkers and therapeutic targets.